A human leptin mutant induces weight gain in normal mice

Area of Science:

• Endocrinology
• Molecular Biology
• Metabolism

Background:

• Leptin is a key hormone regulating appetite and energy balance through receptor binding.
• Understanding leptin's interaction with its receptor is crucial for metabolic research.
• Identifying critical residues in leptin is essential for developing targeted therapies.

Purpose of the Study:

• To identify specific amino acid residues in human leptin essential for receptor binding and biological activity.
• To investigate the in vivo effects of a novel leptin mutant with altered biological activity.

Main Methods:

• Site-directed mutagenesis was employed to create single amino acid substitution mutants of human leptin.
• Receptor binding assays were performed to assess the mutant's affinity for the leptin receptor.
• In vivo studies using C57BL/6J mice were conducted to evaluate the biological activity and effects of the R128Q mutant.

Main Results:

• A specific mutant, R128Q (Arginine to Glutamine at position 128), retained receptor binding but lost biological activity.
• Repeated administration of the R128Q mutant led to a progressive increase in body weight in mice.
• The R128Q mutant demonstrated an ability to interfere with the negative feedback regulation of endogenous leptin.

Conclusions:

• The R128Q leptin mutant acts as an antagonist, blocking endogenous leptin signaling.
• This antagonist property suggests potential therapeutic applications for conditions characterized by weight loss, such as anorexia and cachexia.
• Further research into leptin antagonists could offer novel strategies for managing metabolic disorders.